Literature DB >> 22356185

Thyroid Bethesda reporting category, 'suspicious for papillary thyroid carcinoma', pitfalls and clues to optimize the use of this category.

A Mahajan1, X Lin, R Nayar.   

Abstract

OBJECTIVE: The Bethesda System of Reporting Thyroid Cytopathology classifies the indeterminate categories based on their differing risks of malignancy, as atypia of undetermined significance (AUS), follicular neoplasm/suspicious for follicular neoplasm (FLUS) and suspicious for malignancy. The vast majority of cases of the last category are suspicious for papillary thyroid carcinoma (PTC). The aim of the present study was to identify the pitfalls and clues to improve the usage of the suspicious category as well as improve its outcome of malignancy.
METHODS: We reviewed the cytological features on air dried Diff-Quik® and alcohol-fixed Papanicolaou smears from 54 thyroid fine needle aspirates (FNAs) with surgical follow-up that were originally diagnosed as suspicious. Procedure data/specimen adequacy was correlated and follow-up histology reports were reviewed after our cytological review was completed. Incidental PTC that was not the target of the FNA was excluded from the calculations for correlation.
RESULTS: In our cytological review, we retained a diagnosis of suspicious in 18 of the 54 cases and the remaining 36 were re-categorized as follows: 6 malignant, 10 neoplasm (which is used in our centre instead of FLUS) and 20 AUS. The reasons for overcall of suspicious cases included pseudopapillae, syncytial sheets, nuclear grooves and pinpoint nucleoli in chronic lymphocytic thyroiditis and Hürthle cell neoplasms, and intranuclear inclusions in parathyroid adenoma, hyalinizing trabecular adenoma and mesenchymal repair. The primary reasons for undercall of PTC as suspicious included cystic aspirates with minor features of PTC such as histiocytoid cells, bubblegum colloid, syncytial sheets and cellular swirls. Cases with cytoplasm similar to Hürthle cells were also noted to cause difficulty in accurate classification.
CONCLUSIONS: Recognition of these pitfalls and clues can help improve diagnosis, patient treatment and consequently reduce the number of unnecessary thyroidectomies.
© 2012 Blackwell Publishing Ltd.

Entities:  

Mesh:

Year:  2012        PMID: 22356185     DOI: 10.1111/j.1365-2303.2012.00966.x

Source DB:  PubMed          Journal:  Cytopathology        ISSN: 0956-5507            Impact factor:   2.073


  6 in total

1.  [Fine-needle aspiration (FNA) of the thyroid gland : Analysis of discrepancies between cytological and histological diagnoses].

Authors:  P Dalquen; B Rashed; A Hinsch; R Issa; T Clauditz; A Luebke; J Lüttges; W Saeger; K H Bohuslavizki
Journal:  Pathologe       Date:  2016-09       Impact factor: 1.011

2.  Fine needle aspiration biopsy of thyroid nodules: cytologic and histopathologic correlation of 1096 patients.

Authors:  Ceyhan Ugurluoglu; Fatma Dobur; Pinar Karabagli; Zeliha Esin Celik
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01

3.  Histopathological Review of Diagnostic Categories of the Bethesda System for Reporting Thyroid Cytopathology - An Institutional Experience of 5 Years.

Authors:  Paricha Upadhyaya; Sushil Dhakal; Purbesh Adhikari; Bindu Adhikari; Dibika Khadka; Surya R Niraula
Journal:  J Cytol       Date:  2019 Jan-Mar       Impact factor: 1.000

4.  Cytomorphological Categorization of Thyroid Lesions according to The Bethesda System for Reporting Thyroid Cytology and Correlation with their Histological Outcome: An Indian Oncology Centre Experience.

Authors:  Meenakshi Kamboj; Anurag Mehta; Sunil Pasricha; Gurudutt Gupta; Anila Sharma; Garima Durga
Journal:  J Cytol       Date:  2022-01-31       Impact factor: 1.000

5.  Diagnosis of atypia/follicular lesion of undetermined significance: An institutional experience.

Authors:  Lawrence Q Wong; Virginia A LiVolsi; Zubair W Baloch
Journal:  Cytojournal       Date:  2014-08-28       Impact factor: 2.091

6.  Causes of misdiagnoses by thyroid fine-needle aspiration cytology (FNAC): our experience and a systematic review.

Authors:  Yanli Zhu; Yuntao Song; Guohui Xu; Zhihui Fan; Wenhao Ren
Journal:  Diagn Pathol       Date:  2020-01-03       Impact factor: 2.644

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.